RAGE-mediated inflammation in patients with septic shock

Area of Science:

• Immunology
• Molecular Biology
• Critical Care Medicine

Background:

• The receptor for advanced glycation end-products (RAGE) pathway is integral to the innate immune response in sepsis.
• Understanding RAGE kinetics and its ligands is crucial for sepsis management.

Purpose of the Study:

• To analyze membrane-bound RAGE expression kinetics.
• To quantify soluble RAGE isoforms and metabolic/immunologic ligands.
• To investigate RAGE pathway activation in human inflammatory conditions.

Main Methods:

• Secondary analysis of an observational pilot study.
• Inclusion of patients with septic shock, postoperative controls, and healthy volunteers.
• Flow cytometry for RAGE expression; ELISA for plasma ligands (sRAGE, AGE-CML, S100A8/A9, etc.).

Main Results:

• Septic shock patients showed significantly increased RAGE expression and sRAGE plasma levels.
• AGE-CML formation was protein-dependent; levels did not significantly increase in sepsis.
• Immunologic ligands (S100A8/A9) were significantly elevated in septic patients throughout the study.

Conclusions:

• RAGE pathway activation in septic shock is mainly driven by elevated immunologic ligands.
• Metabolic ligands like AGE-CML play a lesser role in RAGE activation during sepsis.
• Findings highlight the differential contribution of ligand types to RAGE-mediated sepsis pathophysiology.